A drug manufacturer requested judicial review of a recommendation of the Respondent Agency. The Court dismissed the application, finding that the Applicant’s allegation that the Agency secretly or arbitrarily breached a duty of fairness by failing to publish the draft rules of a pilot project, and by failing to strictly follow the draft rules, was without merit.
Administrative law – Judicial review application – Government agencies – Government drug plans – Approval process – Procedural requirements and fairness – Disclosure of rules Boehringer Ingelheim (Canada) Ltd. v. Canadian Agency for Drugs and Technologies in Health, [2008] O.J. No. 4331, Ontario Superior Court of Justice, October 29, 2008, L. K. Ferrier, J. M. ...